| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.002 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.002 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.003 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.003 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.15 | 0.003 |